In two companion papers, we have described the influence of the concentration and the nature of completely dissociated salts dissolved in the mobile phase (methanol:water, 40:60, v/v) on the adsorption behavior of propranolol (R'-NH2+-R, Cl-) on XTerra-C18 and on Symmetry-C18. The same experiments were repeated on a Kromasil-C18 column to compare the adsorption behavior of this ionic compound on these three different RPLC systems. The adsorption data of propranolol hydrochloride were first measured by frontal analysis (FA) using a mobile phase without salt. These data fit best to the Bi-Moreau model. Large concentration band profiles of propranolol were recorded with mobile phases containing increasing KCl concentrations (0, 0.002, 0.005, 0.01, 0.05, 0.1 and 0.2 M) and the best values of the isotherm coefficients were determined using the numerical solution of the inverse problem of chromatography. The general effect of a dissociated salt in the mobile phase was the same as the one observed earlier with XTerra-C18 and Symmetry-C18. However, obvious differences were observed for the shape of the band profiles recorded at low column loading (1.5 g/L, 250 microL injected). A long shoulder is visible at all salt concentrations and the band broadening is maximum at low salt concentrations. A slow mass transfer kinetics on the high-energy sites of the bi-Moreau model might explain this original shape. Five other salts (NaCl, CsCl, KNO3, CaCl2 and Na2SO4) were also used at the same ionic strength (J = 0.2 M). As many different band profiles were observed, suggesting that specific solute-salt interactions take place in the adsorbed phase.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.